Send E-mail
  • LegoChem Bio receives approval for superbacterial antibiotic test
    LegoChem Bio receives approval for superbacterial antibiotic test
    LegoChem Biosciences (141080) announced on Aug. 24 that it has obtained approval from the Ministry of Food and Drug Safety for a phase I clinical study of LCB01-0371, an injectable antibiotic that targets superbacteria. The company added that oral medication is currently undergoing a phase II clinical study and will be later developed in the form of injection.By Yun Jeong-hyeon (clareyun@heraldcorp.com)
From
Send to
Close Send

LegoChem Bio receives approval for superbacterial antibiotic test

Aug. 24, 2016 - 17:35 By 윤정현
[DISCLOSURE] LegoChem Biosciences (141080) announced on Aug. 24 that it has obtained approval from the Ministry of Food and Drug Safety for a phase I clinical study of LCB01-0371, an injectable antibiotic that targets superbacteria.
The company added that oral medication is currently undergoing a phase II clinical study and will be later developed in the form of injection.

By Yun Jeong-hyeon (clareyun@heraldcorp.com)
Most Popular